Free Trial

Oramed Pharmaceuticals (ORMP) Insider Trading & Ownership

→ Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars (From GoldenCrest Metals) (Ad)
Free ORMP Stock Alerts
$2.34
-0.01 (-0.43%)
(As of 09:30 AM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Oramed Pharmaceuticals (NASDAQ:ORMP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.00%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$293,240.00
Number Of
Insiders Selling
(Last 3 Years)
3
Amount Of
Insider Selling
(Last 3 Years)
$5.13 M
Get ORMP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ORMP Insider Buying and Selling by Quarter

Ad GoldenCrest Metals
Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars
Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.
Learn More Now

Oramed Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/16/2023Nadav KidronCEOBuy26,000$2.04$53,040.00  
3/14/2023Nadav KidronCEOBuy100,000$2.01$201,000.00  
3/13/2023Yadin RozovDirectorBuy20,000$1.96$39,200.00  
1/3/2023Michael RabinowitzInsiderSell13,325$12.55$167,228.75  
3/21/2022Kevin RakinDirectorSell10,000$9.41$94,100.00  
1/14/2022Andrew R. GarbarinoU.S. Congress Member (R-NY)Sell$11.05$1,001 - $15,000
10/1/2021Andrew R. GarbarinoU.S. Congress Member (R-NY)Sell$20.93$1,001 - $15,000
9/16/2021Kevin RakinDirectorSell21,100$20.99$442,889.00  
8/9/2021Nadav KidronCEOSell220,000$20.11$4,424,200.00  
(Data available from 1/1/2013 forward)

ORMP Insider Trading Activity - Frequently Asked Questions

Who is on Oramed Pharmaceuticals's Insider Roster?

The list of insiders at Oramed Pharmaceuticals includes Kevin Rakin, Michael Rabinowitz, Nadav Kidron, and Yadin Rozov. Learn more on insiders at ORMP.

What percentage of Oramed Pharmaceuticals stock is owned by insiders?

12.00% of Oramed Pharmaceuticals stock is owned by insiders. Learn more on ORMP's insider holdings.

Which Oramed Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased ORMP shares in the last 24 months: Nadav Kidron ($254,040.00), and Yadin Rozov ($39,200.00).

How much insider buying is happening at Oramed Pharmaceuticals?

Insiders have purchased a total of 146,000 ORMP shares in the last 24 months for a total of $293,240.00 bought.

Which Oramed Pharmaceuticals insiders have been selling company stock?

The following insider sold ORMP shares in the last 24 months: Michael Rabinowitz ($167,228.75).

How much insider selling is happening at Oramed Pharmaceuticals?

Insiders have sold a total of 13,325 Oramed Pharmaceuticals shares in the last 24 months for a total of $167,228.75 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:ORMP) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
SHOCKING Crypto Leak…
Crypto 101 Media
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Elon Musk’s Controversial New Project: “Apollo”
InvestorPlace
New Trump Bombshell
The Freeport Society
The Greatest Bull Market in Crypto History…
Weiss Ratings